Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR
Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1437-1438
DOI: 10.1111/apt.70595 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 07.03.2026. Verfasst von Zhejin Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Department of Postgraduate Training, Base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, China.
ORCID-Profile: Zichen Yu
Zitieren
APA
Shi, Z., Li, H., & Yu, Z. (2026). Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR. Alimentary Pharmacology & Therapeutics, 63(10), 1437-1438. https://doi.org/10.1111/apt.70595
Vancouver
Shi Z, Li H, Yu Z. Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR. Alimentary Pharmacology & Therapeutics. 2026;63(10):1437-1438. doi:10.1111/apt.70595
BibTeX
@article{Shi2026,
author = {Shi, Zhejin and Li, Haoyi and Yu, Zichen},
title = {Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {10},
pages = {1437--1438},
doi = {10.1111/apt.70595}
}
EUVIMED